MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE): MAHAMAYA LIFESCIENCES Share Price Rises 8.33% Today

MAHAMAYA LIFESCIENCES Share Price Today rose to Rs 184, up 8.33%, taking market capitalisation to Rs 397.53 crore in a notable BSE move.

MAHAMAYA LIFESCIENCES Share Price moved up sharply on 10 August 2026, with the stock trading at Rs 184, up Rs 14.15 or 8.33% from the previous close of Rs 169.85. With market capitalisation at Rs 397.53 crore, the move placed the company among today’s notable micro-cap gainers on the BSE and made it relevant for investors tracking Stocks in News, Top Gainers Today and price action-led market movers.

The supplied data confirms a same-day price rise event in MAHAMAYA LIFESCIENCES Share Price and shows that the stock qualified under the workflow’s Micro Cap price-rise screen. The stock opened at Rs 176.95, stayed above the previous close through the session, touched an intraday high of Rs 184 and a low of Rs 176, and reached its session high at the current traded price. That pattern matters because it points to firm intraday follow-through rather than a fleeting opening spike.

For readers looking for MAHAMAYA LIFESCIENCES Stock News, the verified dataset establishes the move in price, volume and valuation, but it does not establish a company-specific catalyst. That means today’s article from Univest focuses on what can be confirmed: the magnitude of the share price gain, the BSE trading activity behind it, how the stock is valued relative to its pesticides and agrochemicals industry benchmark, and where it sits against listed peers. For investors scanning the Indian Stock Market and Share Market Today, the next step is not speculation but understanding whether this MAHAMAYA LIFESCIENCES Share Price rise is supported by reasonable financial metrics and industry positioning.

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) Share Price Today: Price Action Analysis

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) traded at Rs 184. versus the previous close of Rs 169.85, a rise of 8.33%. The stock opened at Rs 176.95, reached Rs 184, touched Rs 176. Reported volume was 38,400.

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) Fundamental Analysis

MAHAMAYA LIFESCIENCES LIMITED was valued at a P/E ratio of 24.06x, a P/B ratio of 3.5x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 17.34% and ROCE of 16.12%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 7.06, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

MAHAMAYA LIFESCIENCES Share Price is attracting attention because the company combines a micro-cap size with mid-range profitability ratios and valuation multiples that can now be measured against its industry benchmark rather than viewed in isolation.

From a market-value perspective, MAHAMAYA LIFESCIENCES has a market capitalisation of Rs 397.53 crore. That places it below the industry benchmark median market cap of Rs 464.32 crore and well below the benchmark average of Rs 772.73 crore across 25 same-industry companies. Size alone does not say whether a business is attractive, but it does frame the stock as a smaller listed participant within the pesticides and agrochemicals space.

On valuation, the stock trades at a P/E ratio of 24.06 and a P/B ratio of 3.5. Those are not just standalone figures. Against the same-industry benchmark, the company’s P/E is above the median of 16.98 and above the average of 20.56, while its P/B is above the median of 1.77 and above the average of 1.98. The benchmark range also matters: industry P/E spans 9.74 to 51.59, and industry P/B ranges from 0.69 to 4.35. That means MAHAMAYA LIFESCIENCES Share Price is valued toward the higher side of the industry on both earnings and book value metrics, though still within the observed peer range.

Profitability is mixed rather than one-directional. Return on equity stands at 17.34%, slightly above the benchmark median of 14.88% and very close to the average of 17.58%. Return on capital employed is 16.12%, just below the benchmark median of 16.59% and materially below the average of 21.41%. This suggests the company’s equity returns are competitive within the group, while capital efficiency is nearer the middle-to-lower part of the peer set.

EPS comes in at 7.06, showing the earnings attributable to each share based on the supplied data. Dividend yield is 0, which indicates no current historical yield contribution at the present price. Taken together, MAHAMAYA LIFESCIENCES Fundamental Analysis suggests that the stock’s valuation already discounts a measure of profitability quality, so today’s share price rise draws attention because investors are paying above-industry-median multiples for a company whose ROE is respectable but whose ROCE is not industry-leading. That naturally shifts the analysis toward sector positioning and peer comparison.

Sector and Industry Context

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) is classified under sector: Chemicals and industry: Pesticides & Agrochemicals.

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has a P/E ratio of 24.06x, which is above the benchmark median of 16.98x, a difference of +41.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has a ROE of 17.34%, which is above the benchmark median of 14.88%, a difference of +16.53%. MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has a ROCE of 16.12%, which is below the benchmark median of 16.59%, a difference of -2.83%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

MAHAMAYA LIFESCIENCES Share Price sits within the Chemicals sector and the Pesticides & Agrochemicals industry, where benchmark data across 25 same-industry companies gives investors a clearer way to judge today’s move in context.

The most useful benchmark in the supplied dataset is the same-industry snapshot covering 25 companies. MAHAMAYA LIFESCIENCES is part of Chemicals, specifically Pesticides & Agrochemicals, and its P/E ratio of 24.06 stands above the industry median of 16.98 and the average of 20.56. Since the benchmark P/E range runs from 9.74 to 51.59 based on 20 companies, the company is not at the top of the range, but it does trade at a premium to central industry levels.

The same pattern appears on book value. MAHAMAYA LIFESCIENCES has a P/B ratio of 3.5, compared with an industry median of 1.77 and average of 1.98 across 25 companies. The industry P/B range extends from 0.69 to 4.35, placing the stock near the upper end of the observed valuation band. For investors following MAHAMAYA LIFESCIENCES Share Price News, that suggests the market is assigning a relatively stronger valuation multiple than the typical company in its segment.

On profitability, the comparison is more balanced. ROE of 17.34% is above the industry median of 14.88% and only slightly below the average of 17.58%, indicating broadly competitive shareholder returns. ROCE of 16.12%, however, is below the median of 16.59% and below the average of 21.41%, showing that capital-use efficiency trails stronger operators in the benchmark set. Market capitalisation of Rs 397.53 crore is lower than the median of Rs 464.32 crore and well below the average of Rs 772.73 crore, so MAHAMAYA LIFESCIENCES Share Price is being valued at premium multiples despite a smaller scale relative to the benchmark universe. That contrast is central to today’s stock analysis.

Peer Comparison

MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has a P/E ratio of 24.06x compared with the displayed peer median of 15.51x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.34% compares with a peer median of 25.38% across the companies shown in the table. ROCE stood at 16.12% versus the displayed peer median of 23.5%, providing a capital-efficiency comparison. MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) has a market capitalisation of Rs 397.53 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

MAHAMAYA LIFESCIENCES Share Price looks most interesting when compared with listed pesticides and agrochemicals peers on valuation, profitability and scale, because today’s price rise comes in a segment where benchmark multiples vary widely.

Against GSP Crop Science, MAHAMAYA LIFESCIENCES trades at a lower P/E of 24.06 versus 28.4 and a slightly lower P/B of 3.5 versus 3.6, but it also has lower profitability, with ROE of 17.34% versus 18.63% and ROCE of 16.12% versus 23.5. The scale gap is substantial, as GSP Crop Science’s market cap is Rs 2,779.96 crore.

Versus Bharat Rasayan, the company appears more expensive on earnings, since Bharat Rasayan trades at 15.51 times earnings with P/B of 1.77, while also delivering much stronger ROE of 25.38% and ROCE of 30.45%. India Pesticides and Dharmaj Crop Guard show a similar contrast: both have lower P/E ratios of 15.53 and 14.96 respectively, yet much higher ROE and ROCE than MAHAMAYA LIFESCIENCES.

In comparison with Insecticides (India), the picture is less one-sided. MAHAMAYA LIFESCIENCES has a higher P/E of 24.06 against 13.46 and a higher P/B of 3.5 against 1.54, but its ROE of 17.34% is stronger than Insecticides (India)’s 12.71%, while ROCE is nearly identical at 16.12% versus 16.13. Against Meghmani Organics, MAHAMAYA LIFESCIENCES has a higher P/E and sharply higher P/B, while ROE is only marginally better at 17.34% versus 17.27 and ROCE is lower at 16.12% versus 19.59.

The peer set therefore shows a clear pattern for MAHAMAYA LIFESCIENCES Share Price: the stock is smaller than all ten supplied peers, yet trades at valuation multiples that are above many of them. Its profitability is competitive with a few peers on ROE, but not dominant across the group, especially on ROCE. That does not negate today’s price rise, but it does mean peer comparison remains essential when judging how much operating quality is already reflected in the stock price.

Why Investors Are Watching MAHAMAYA LIFESCIENCES

MAHAMAYA LIFESCIENCES Share Price is being watched because today’s move combines a meaningful single-session gain, a close near the day’s high, and valuation ratios that already sit above key industry medians. In a micro-cap stock, that combination often draws attention from traders focused on price action and from investors comparing market cap, profitability and peer positioning.

• Verified price action: the stock rose 8.33% to Rs 184 from Rs 169.85 and traded between Rs 176 and Rs 184.
• Trading activity: 38,400 shares changed hands on the BSE with turnover of Rs 0.71 crore.
• Market-cap context: MAHAMAYA LIFESCIENCES remains a Micro Cap company with market capitalisation of Rs 397.53 crore.
• Valuation lens: P/E of 24.06 and P/B of 3.5 are above the industry medians of 16.98 and 1.77.
• Profitability context: ROE of 17.34% is above the industry median, while ROCE of 16.12% is slightly below it.
• Sector position: the stock operates in Chemicals, specifically Pesticides & Agrochemicals, where peer multiples and returns vary significantly.

What investors may monitor next is whether MAHAMAYA LIFESCIENCES Share Price continues to hold near the upper end of its recent trading range and whether its premium valuation remains justified against peer profitability. For readers following Stock Market Today and Market News on Univest, today’s move is notable because the data shows a real price rise with measurable turnover, but the valuation backdrop remains as important as the intraday gain itself.

About MAHAMAYA LIFESCIENCES

MAHAMAYA LIFESCIENCES LIMITED is classified in the Chemicals sector and operates within the Pesticides & Agrochemicals industry. Even with limited company-specific business description in the supplied dataset, that classification is useful because it places the business in a listed segment where investors frequently track valuation, profitability and scale alongside broader agricultural-input demand trends.

Within this industry universe, the benchmark snapshot covers 25 companies, ranging in market capitalisation from Rs 8.17 crore to Rs 2,779.96 crore. MAHAMAYA LIFESCIENCES, at Rs 397.53 crore, sits below the group median and far below the largest listed players in the same space. That makes it a smaller participant in an industry where several larger peers such as GSP Crop Science, Bharat Rasayan, Insecticides (India) and India Pesticides operate at meaningfully bigger scale.

For investors reading MAHAMAYA LIFESCIENCES Stock News and MAHAMAYA LIFESCIENCES Share News, the company’s industry matters because pesticides and agrochemicals stocks are often compared through earnings multiples, book-value multiples and return ratios. In that setting, MAHAMAYA LIFESCIENCES stands out less for size and more for how the market currently values it relative to the benchmark. Univest therefore views the company primarily through the lens of its verified sector classification, market capitalisation and relative financial metrics, which together offer the clearest current Company Overview from the supplied data.

Track MAHAMAYA LIFESCIENCES Share Price on Univest

Use MAHAMAYA LIFESCIENCES LIMITED (MAHALIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who want to follow MAHAMAYA LIFESCIENCES Share Price more closely can use Univest to track live share price moves, daily percentage changes, market capitalisation, valuation ratios and peer comparison in one place. Univest also helps users monitor 52-week levels, company financial ratios, sector context and market updates that matter when a stock enters the top-gainer list.

For readers searching MAHAMAYA LIFESCIENCES Share Price Live, MAHAMAYA LIFESCIENCES Latest News or MAHAMAYA LIFESCIENCES Stock Analysis, Univest provides a structured way to compare price action with fundamentals instead of looking at a day gain in isolation. That is particularly useful in micro-cap names where a visible share price rise may attract attention quickly, but context from valuation and industry benchmarks remains essential.

Frequently Asked Questions

What is MAHAMAYA LIFESCIENCES Share Price Today?

Ans. MAHAMAYA LIFESCIENCES Share Price Today was Rs 184 at the time of the article. The stock was up Rs 14.15, or 8.33%, from the previous close of Rs 169.85 in BSE trade.

Why is MAHAMAYA LIFESCIENCES Share Price rising today?

Ans. The supplied data confirms that MAHAMAYA LIFESCIENCES Share Price rose 8.33% today and qualified under the Micro Cap price-rise screen. The dataset verifies the move, volume and turnover, but not a company-specific catalyst.

What was the previous close of MAHAMAYA LIFESCIENCES shares?

Ans. The previous close for MAHAMAYA LIFESCIENCES shares was Rs 169.85. From that base, the stock gained Rs 14.15 to Rs 184, making it one of the session’s notable micro-cap gainers.

What does today’s intraday range show for MAHAMAYA LIFESCIENCES?

Ans. The stock opened at Rs 176.95, touched a low of Rs 176 and a high of Rs 184. With the current price also at Rs 184, MAHAMAYA LIFESCIENCES ended near the top of its session range.

What is the market capitalisation of MAHAMAYA LIFESCIENCES?

Ans. MAHAMAYA LIFESCIENCES has a market capitalisation of Rs 397.53 crore. That places it in the Micro Cap category and below the same-industry median market cap of Rs 464.32 crore. The company operates in the Chemicals sector.

How much volume was traded in MAHAMAYA LIFESCIENCES today?

Ans. Total traded volume in MAHAMAYA LIFESCIENCES stood at 38,400 shares, all reported on the BSE in the supplied dataset. Turnover for the session was Rs 0.71 crore alongside the 8.33% price rise.

Is MAHAMAYA LIFESCIENCES expensive compared with its industry?

Ans. On supplied benchmark data, MAHAMAYA LIFESCIENCES trades above industry central valuation levels. Its P/E is 24.06 versus the median 16.98, while its P/B is 3.5 versus the median 1.77. The stock belongs to the Chemicals sector.

How profitable is MAHAMAYA LIFESCIENCES based on ROE and ROCE?

Ans. MAHAMAYA LIFESCIENCES reports ROE of 17.34% and ROCE of 16.12%. Its ROE is above the industry median of 14.88%, while ROCE is slightly below the median of 16.59%. ROE stands at 17.34%.

Which sector and industry does MAHAMAYA LIFESCIENCES belong to?

Ans. MAHAMAYA LIFESCIENCES belongs to the Chemicals sector and the Pesticides & Agrochemicals industry. The benchmark comparison in this article uses 25 same-industry companies to place its valuation and profitability in context.